Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 19 of 123)
- Relevance
  Sort by

Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029

 Report
November 2023
1800 Pages
Global

From

€4642EUR$5,100USD£3,979GBP

Schizophrenia Drugs Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4504EUR$4,949USD£3,861GBP

Hydroxyurea Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
74 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

CD137 Antibodies Clinical Trials & Market Opportunity Insight

 Report
September 2024
210 Pages
Global

From

€2184EUR$2,400USD£1,873GBP

Stroke Therapeutics Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

 Report
August 2022
110 Pages
Global

From

€4323EUR$4,750USD£3,706GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028

 Report
August 2024
195 Pages
Global

From

€2184EUR$2,400USD£1,873GBP

Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
78 Pages
Asia Pacific

From

€4323EUR$4,750USD£3,706GBP

Cephalosporin Market Report by Generation, Route of Administration, Application, and Region ?2025-2033

 Report
February 2025
144 Pages
Global

From

€2729EUR$2,999USD£2,340GBP

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
245 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Monoclonal Antibodies - Global Strategic Business Report

 Report
April 2025
213 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
83 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Glioblastoma Multiforme Treatment Market Report and Forecast 2024-2032

 Report
September 2023
200 Pages
Global

From

€3275EUR$3,599USD£2,808GBP

Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Forecast to 2029

 Report
May 2024
535 Pages
Global

From

€4505EUR$4,950USD£3,862GBP

Ketolides Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Global Cell Therapy Biomanufacturing Market 2024-2029

 Report
August 2024
112 Pages
Global

From

€4232EUR$4,650USD£3,628GBP

Medulloblastoma - Pipeline Insight, 2024

 Clinical Trials
April 2024
50 Pages
Global

From

€1365EUR$1,500USD£1,170GBP

Rnai Drug Delivery Market 2024-2028

 Report
July 2024
180 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
May 2022
548 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
May 2022
1381 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Aminoglycosides Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

2,452 Results (Page 19 of 123)
- 1
- 17
- 18
- 19
- 20
- 21

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.